Analysis_NN
of_IN
the_DT
ligand-binding_JJ
domain_NN
of_IN
human_JJ
retinoic_JJ
acid_NN
receptor_NN
alpha_NN
by_IN
site-directed_JJ
mutagenesis_NN
._.

Three_CD
subtypes_NNS
of_IN
retinoic_JJ
acid_NN
receptors_NNS
-LRB-_-LRB-
RAR_NN
-RRB-_-RRB-
,_,
termed_VBN
RAR_NN
alpha_NN
,_,
RAR_NN
beta_NN
,_,
and_CC
RAR_NN
gamma_NN
,_,
have_VBP
been_VBN
described_VBN
._.

They_PRP
are_VBP
composed_VBN
of_IN
different_JJ
structural_JJ
domains_NNS
,_,
including_VBG
distinct_JJ
domains_NNS
for_IN
DNA_NN
and_CC
ligand_NN
binding_NN
._.

RARs_NNS
specifically_RB
bind_VBP
all-trans-retinoic_JJ
acid_NN
-LRB-_-LRB-
RA_NN
-RRB-_-RRB-
,_,
9-cis-RA_NN
,_,
and_CC
retinoid_NN
analogs_NNS
._.

In_IN
this_DT
study_NN
,_,
we_PRP
examined_VBD
the_DT
functional_JJ
role_NN
of_IN
cysteine_NN
and_CC
arginine_NN
residues_NNS
in_IN
the_DT
ligand-binding_JJ
domain_NN
of_IN
hRAR_NN
alpha_NN
-LRB-_-LRB-
hRAR_NN
alpha-LBD_NN
,_,
amino_NN
acids_NNS
154_CD
to_TO
462_CD
-RRB-_-RRB-
._.

All_DT
conserved_VBN
cysteine_NN
and_CC
arginine_NN
residues_NNS
in_IN
this_DT
domain_NN
were_VBD
mutated_VBN
by_IN
site-directed_JJ
mutagenesis_NN
,_,
and_CC
the_DT
mutant_JJ
proteins_NNS
were_VBD
characterized_VBN
by_IN
blocking_VBG
reactions_NNS
,_,
ligand-binding_JJ
experiments_NNS
,_,
transactivation_NN
assays_NNS
,_,
and_CC
protease_NN
mapping_NN
._.

Changes_NNS
of_IN
any_DT
cysteine_NN
residue_NN
of_IN
the_DT
hRAR_NN
alpha-LBD_NN
had_VBD
no_DT
significant_JJ
influence_NN
on_IN
the_DT
binding_NN
of_IN
all-trans_JJ
RA_NN
or_CC
9-cis_JJ
RA_NN
._.

Interestingly_RB
,_,
residue_NN
C-235_NN
is_VBZ
specifically_RB
important_JJ
in_IN
antagonist_NN
binding_NN
._.

With_IN
respect_NN
to_TO
arginine_NN
residues_NNS
,_,
only_RB
the_DT
two_CD
single_JJ
mutations_NNS
of_IN
R-276_NN
and_CC
R-394_NN
to_TO
alanine_NN
showed_VBD
a_DT
dramatic_JJ
decrease_NN
of_IN
agonist_NN
and_CC
antagonist_NN
binding_NN
whereas_IN
the_DT
R272A_NN
mutation_NN
showed_VBD
only_RB
a_DT
slight_JJ
effect_NN
._.

For_IN
all_DT
other_JJ
arginine_NN
mutations_NNS
,_,
no_DT
differences_NNS
in_IN
affinity_NN
were_VBD
detectable_JJ
._.

The_DT
two_CD
mutations_NNS
R217A_NN
and_CC
R294A_NN
caused_VBD
an_DT
increased_VBN
binding_NN
efficiency_NN
for_IN
antagonists_NNS
but_CC
no_DT
change_NN
in_IN
agonist_NN
binding_NN
._.

From_IN
these_DT
results_NNS
,_,
we_PRP
can_MD
conclude_VB
that_IN
electrostatic_JJ
interactions_NNS
of_IN
retinoids_NNS
with_IN
the_DT
RAR_NN
alpha-LBD_NN
play_VBP
a_DT
significant_JJ
role_NN
in_IN
ligand_NN
binding_NN
._.

In_IN
addition_NN
,_,
antagonists_NNS
show_VBP
distinctly_RB
different_JJ
requirements_NNS
for_IN
efficient_JJ
binding_NN
,_,
which_WDT
may_MD
contribute_VB
to_TO
their_PRP$
interference_NN
in_IN
the_DT
ligand-inducible_JJ
transactivation_NN
function_NN
of_IN
RAR_NN
alpha_NN
._.

